The oral BTK inhibitor rilzabrutinib led to rapid and durable platelet responses, reduced bleeding, and improved fatigue in ...

The machine learning model shows promise in detecting paroxysmal nocturnal hemoglobinuria (PNH) by assessing electronic health records (EHR) data, potentially transforming the diagnostic landscape ...

Discover a rare case linking cytomegalovirus (CMV) infection to severe immune thrombocytopenic purpura (ITP) in a healthy adult. Learn about diagnosis and treatment challenges.

EAST RUTHERFORD, N.J. - On Friday, New York Giants outside linebacker Kayvon Thibodeaux, along with Dr. Samuel A. Taylor, ...

They can take a while to show up and may resolve themselves after a few months. Treatment of White Spots on Skin Depending on the cause, you may or may not be able to get rid of the white spots on ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66th American ...

The present review highlights occurrence, diagnosis, complications, surveillance, corticosteroid treatment, mode of delivery and risk of recurrence. Methods: Clinical reports and reviews published ...

Incredible progress is being made in health and medicine – every day we seem to broaden our understanding of how to maximize physical and mental health, treat and cure illness and disease ...

Positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP), a rare immune-mediated disease, reinforce the efficacy and ...

ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP Pivotal phase 3 data show rapid and durable platelet response, reduced ...